Who backs Silver Creek Pharmaceuticals?
8 investors| Investor | Type |
|---|---|
| Catalytik Group | — |
| Crocker Ventures | — |
| Lung | — |
| Mark Agne | — |
| National Heart | — |
| Nicholas Taylor | — |
| QB3 | — |
| and Blood Institute | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Silver Creek Pharmaceuticals investors
8 investors are on record for Silver Creek Pharmaceuticals, including Catalytik Group, Crocker Ventures, Lung and Mark Agne. The early-stage round in Jan 2022 drew 22 investors.
Free account
More of Silver Creek Pharmaceuticals with a free account
- ·Watch Silver Creek Pharmaceuticals: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 8 firms already write checks for companies like Silver Creek Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View